Humana Files 8-K on Operations & Financial Condition

TL;DR

**Humana just dropped an 8-K on its financials, get ready for potential stock movement.**

AI Summary

Humana Inc. filed an 8-K on January 18, 2024, to report on its results of operations and financial condition, as well as to make a Regulation FD Disclosure. This filing indicates that Humana is providing an update on its financial performance, which is crucial for investors to understand the company's current health and future prospects. For stockholders, this matters because it provides timely information that could influence the stock's price and their investment decisions.

Why It Matters

This filing signals that Humana is updating the market on its financial performance, which can directly impact investor confidence and stock valuation. Investors should pay close attention to the details of the financial condition and results of operations.

Risk Assessment

Risk Level: medium — While an 8-K itself isn't inherently risky, the 'Results of Operations and Financial Condition' item suggests important financial updates that could contain positive or negative news, creating uncertainty.

Analyst Insight

A smart investor would await the full details of the 'Results of Operations and Financial Condition' and 'Regulation FD Disclosure' to understand the specific financial updates and their implications before making any investment decisions.

Key Players & Entities

• Humana Inc. (company) — the registrant filing the 8-K
• January 18, 2024 (date) — date of earliest event reported and filing date
• 500 West Main Street, Louisville, KY 40202 (address) — principal executive offices of Humana Inc.
• 0000049071 (number) — Central Index Key (CIK) for Humana Inc.
• 1-5975 (number) — Commission File Number for Humana Inc.

FAQ

From the Filing

0000049071-24-000005.txt : 20240118 0000049071-24-000005.hdr.sgml : 20240118 20240118063709 ACCESSION NUMBER: 0000049071-24-000005 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20240118 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20240118 DATE AS OF CHANGE: 20240118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANA INC CENTRAL INDEX KEY: 0000049071 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 610647538 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-05975 FILM NUMBER: 24540089 BUSINESS ADDRESS: STREET 1: 500 W MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 BUSINESS PHONE: 5025801000 MAIL ADDRESS: STREET 1: 500 W. MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 FORMER COMPANY: FORMER CONFORMED NAME: EXTENDICARE INC DATE OF NAME CHANGE: 19740404 FORMER COMPANY: FORMER CONFORMED NAME: HERITAGE HOUSE OF AMERICA INC DATE OF NAME CHANGE: 19671129 8-K 1 hum-20240118.htm 8-K hum-20240118 0000049071 false 0000049071 2024-01-18 2024-01-18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K                  CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):  January 18, 2024 (January 18, 2024) Humana Inc. (Exact name of registrant as specified in its charter) Delaware 1-5975 61-0647538 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 500 West Main Street Louisville , KY 40202 (Address of principal executive offices, including zip code) 502 - 580-1000 (Registrant’s telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock HUM New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐ Item 2.02 Results of Operations and Financial Condition. Item 7.01 Regulation FD Disclosure. 2024 Individual Medicare Advantage Enrollment Based on the results of the annual election period (AEP), Humana Inc. (the “Company”) now expects individual Medicare Advantage (MA) growth of approximately 100,000 members for the year ending December 31, 2024, representing 1.8 percent growth over its membership as of December 31, 2023 of approximately 5.4 million members, compared to its previous commentary of ‘at or slightly above industry average growth’. The Company’s mem